mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |